Information disclosure in Oracle Life Sciences Central Designer
CVE-2026-21974
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Vulnerability class: Information Disclosure
EPSS: 0.002 (12.5th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.
Affected products
- Oracle Life_sciences_central_designer — versions 7.0.1.0
- Oracle Corporation Life Sciences Central Designer — versions 7.0.1.0
Weakness classification (CWE)
References
- secalert_us@oracle.com (vendor-advisory, Vendor Advisory)
Frequently asked questions
- What is CVE-2026-21974?
- CVE-2026-21974 is a medium-severity vulnerability in Oracle Life Sciences Central Designer, classified under Information Disclosure. CVSS score: 5.3/10. Published 2026-01-20.
- How severe is CVE-2026-21974?
- Medium severity. CVSS v3 base score is 5.3 out of 10.